Aclaris Therapeutics (ACRS) Files $300M Mixed Shelf

November 3, 2016 12:03 PM EDT
Get Alerts ACRS Hot Sheet
Trade ACRS Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Aclaris Therapeutics (Nasdaq: ACRS) filed a registration with the U.S. SEC to sell up to $300 million of mixed securities.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Equity Offerings

Add Your Comment